| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/1354750X.2017.1405283 |
| P698 | PubMed publication ID | 29130350 |
| P50 | author | Andrzej Konieczny | Q59095259 |
| Remigiusz Bąchor | Q88903867 | ||
| Krystyna Dabrowska | Q89854851 | ||
| Zbigniew Szewczuk | Q38639367 | ||
| P2093 | author name string | Wojciech Witkiewicz | |
| Ewa Milewska | |||
| Karolina Panek-Laszczyńska | |||
| P2860 | cites work | Urinary proteomics for prediction of preeclampsia | Q39797354 |
| Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia | Q40142875 | ||
| The hydrogen-deuterium exchange at α-carbon atom in N,N,N-trialkylglycine residue: ESI-MS studies | Q41780251 | ||
| Quantitative polymerase chain reaction-based analysis of podocyturia is a feasible diagnostic tool in preeclampsia | Q46322061 | ||
| Severe preeclampsia at <25 weeks of gestation: maternal and neonatal outcomes | Q46351518 | ||
| Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria | Q46437231 | ||
| Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases. | Q53479258 | ||
| Urinary podocyte excretion as a marker for preeclampsia. | Q53562117 | ||
| Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria | Q58214894 | ||
| Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study | Q24597867 | ||
| Multidimensional proteomics for cell biology | Q27008027 | ||
| Expression of podocyte-associated molecules in acquired human kidney diseases | Q28188737 | ||
| Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data | Q28211057 | ||
| Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia | Q28285163 | ||
| Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis | Q30241836 | ||
| Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus. | Q31074551 | ||
| Podocalyxin is a novel polysialylated neural adhesion protein with multiple roles in neural development and synapse formation | Q33656642 | ||
| A comparison of podocyturia, albuminuria and nephrinuria in predicting the development of preeclampsia: a prospective study | Q33882317 | ||
| Urinary protein markers predict the severity of renal histological lesions in children with mesangial proliferative glomerulonephritis | Q34274186 | ||
| The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis | Q34540601 | ||
| Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis | Q34708320 | ||
| Podocyte biology and response to injury | Q35005456 | ||
| Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside | Q35041246 | ||
| Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study | Q35720653 | ||
| Placental-related diseases of pregnancy: Involvement of oxidative stress and implications in human evolution | Q35810254 | ||
| Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy | Q36120785 | ||
| Alteration of podocyte phenotype in the urine of women with preeclampsia | Q36773959 | ||
| Mass spectrometry as a novel method for detection of podocyturia in pre-eclampsia | Q36936580 | ||
| Biomarker discovery in mass spectrometry-based urinary proteomics | Q36956324 | ||
| Mass spectrometry based targeted protein quantification: methods and applications | Q37134146 | ||
| Glomerular epithelial cells in the urine: what has to be done to make them worthwhile? | Q37289620 | ||
| Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review | Q37665733 | ||
| Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. | Q37776132 | ||
| Evaluation of biomarkers for the prediction of pre-eclampsia in women with type 1 diabetes mellitus: A systematic review | Q38743472 | ||
| The competition of charge remote and charge directed fragmentation mechanisms in quaternary ammonium salt derivatized peptides--an isotopic exchange study | Q39253432 | ||
| Altered nephrin and podoplanin distribution is associated with disturbed polarity protein PARD-3 and PARD-6 expressions in podocytes from preeclampsia | Q39573170 | ||
| Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort. | Q39783174 | ||
| P921 | main subject | pre-eclampsia | Q61335 |
| maternal health | Q6786626 | ||
| diagnostic marker | Q129938486 | ||
| P304 | page(s) | 1-6 | |
| P577 | publication date | 2017-11-13 | |
| P1433 | published in | Biomarkers | Q4915076 |
| P1476 | title | Podocyturia as an early diagnostic marker of preeclampsia: a literature review |
| Q92622710 | Early Detection of Active Glomerular Lesions in Dogs and Cats Using Podocin |
| Q90520095 | Enrichment of Cysteine-Containing Peptide by On-Resin Capturing and Fixed Charge Tag Derivatization for Sensitive ESI-MS Detection |
| Q92905172 | Evaluation of Tryptic Podocin Peptide in Urine Sediment Using LC-MS-MRM Method as a Potential Biomarker of Glomerular Injury in Dogs with Clinical Signs of Renal and Cardiac Disorders |
Search more.